Stock Track | Icon PLC Soars 5.98% as Analysts Maintain Buy Ratings and Optimistic Outlooks

Stock Track

02-20

Shares of Icon PLC, a global provider of outsourced drug and device development and commercialization services, surged 5.98% in Thursday's pre-market trading session. The stock's rally comes after two analysts reiterated their Buy ratings on the company, citing positive outlooks.

Truist Financial analyst Jailendra Singh maintained a Buy rating on Icon, highlighting the company's strong financial performance and growth prospects. Singh expressed optimism about Icon's ability to capitalize on the increasing demand for outsourced clinical research services.

Additionally, TD Cowen analyst Charles Rhyee maintained a Buy rating on Icon, with a price target of $254.00. Rhyee's report emphasized Icon's diversified service offerings and robust pipeline as key drivers for future growth.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1173135100"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1173135100\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1173135100?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-20 22:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1173135100","market":"us","top_or_hot":-1,"title":"Stock Track | Icon PLC Soars 5.98% as Analysts Maintain Buy Ratings and Optimistic Outlooks","media":"Stock Track","content":"<p>Shares of Icon PLC, a global provider of outsourced drug and device development and commercialization services, surged 5.98% in Thursday's pre-market trading session. The stock's rally comes after two analysts reiterated their Buy ratings on the company, citing positive outlooks.</p>\n\n<p>Truist Financial analyst Jailendra Singh maintained a Buy rating on Icon, highlighting the company's strong financial performance and growth prospects. Singh expressed optimism about Icon's ability to capitalize on the increasing demand for outsourced clinical research services.</p>\n\n<p>Additionally, TD Cowen analyst Charles Rhyee maintained a Buy rating on Icon, with a price target of $254.00. Rhyee's report emphasized Icon's diversified service offerings and robust pipeline as key drivers for future growth.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Icon PLC Soars 5.98% as Analysts Maintain Buy Ratings and Optimistic Outlooks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Icon PLC Soars 5.98% as Analysts Maintain Buy Ratings and Optimistic Outlooks\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2025-02-20 22:39</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shares of Icon PLC, a global provider of outsourced drug and device development and commercialization services, surged 5.98% in Thursday's pre-market trading session. The stock's rally comes after two analysts reiterated their Buy ratings on the company, citing positive outlooks.</p>\n\n<p>Truist Financial analyst Jailendra Singh maintained a Buy rating on Icon, highlighting the company's strong financial performance and growth prospects. Singh expressed optimism about Icon's ability to capitalize on the increasing demand for outsourced clinical research services.</p>\n\n<p>Additionally, TD Cowen analyst Charles Rhyee maintained a Buy rating on Icon, with a price target of $254.00. Rhyee's report emphasized Icon's diversified service offerings and robust pipeline as key drivers for future growth.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ICLR","symbol_name":"ICON plc","start_time":0,"source_url":"","article_id":"1173135100","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1173135100","pubTimestamp":1740062356,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Icon PLC, a global provider of outsourced drug and device development and commercialization services, surged 5.98% in Thursday's pre-market trading session. The stock's rally comes after two analysts reiterated their Buy ratings on the company, citing positive outlooks.Truist Financial analyst Jailendra Singh maintained a Buy rating on Icon, highlighting the company's strong financial performance and growth prospects. Singh expressed optimism about Icon's ability to capitalize on the i","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ICLR":"ICON plc"},"translate_title":"分析师维持买入评级和乐观前景，股票赛道Icon PLC飙升5.98%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ICLR":1},"content_text":"Shares of Icon PLC, a global provider of outsourced drug and device development and commercialization services, surged 5.98% in Thursday's pre-market trading session. The stock's rally comes after two analysts reiterated their Buy ratings on the company, citing positive outlooks.\nTruist Financial analyst Jailendra Singh maintained a Buy rating on Icon, highlighting the company's strong financial performance and growth prospects. Singh expressed optimism about Icon's ability to capitalize on the increasing demand for outsourced clinical research services.\nAdditionally, TD Cowen analyst Charles Rhyee maintained a Buy rating on Icon, with a price target of $254.00. Rhyee's report emphasized Icon's diversified service offerings and robust pipeline as key drivers for future growth.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1}}}